Université libre de Bruxelles has added a fourth Theodorus fund to its arsenal with an initial close of $23m and a target of up to $33.5m.

The Tengelmann-backed classical music streaming platform has doubled its overall funding by raising $11.8m as it expands to North America.

Jamie Rowles has left a venture capital position at Jetstone Asset Management to head Sky’s impact venturing fund.

GSK is the second largest shareholder of gene therapy developer Orchard Therapeutics, which has raised more than $290m in equity funding.

The UCL Technology Fund is in line for an exit from gene therapy developer Orchard Therapeutics, which has raised more than $290m in equity funding.

Oxford regenerative medicine spinout OxStem, which raised $24.4m in 2016, has launched two subsidiaries to focus on therapies for diabetes, chronic inflammation and wound healing.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

KIT-founded valve actuator manufacturer Memetis has received capital from the university and HTGF to help expand development and production.

Advanced battery developer Aceleron, which operates from Birmingham and Brunel universities, has been backed by the Midlands Engine Investment Fund.

Fresh from leading the flower delivery service's last round, Burda Principal Investments has come back for a $19.5m round that will fund entry into new markets.